Published

Use of MDMA & Psilocybin in the Treatment of PTSD

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: PDXScholar (Portland State University)
Date: 2018-12-31
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Camden Grant-Howard Joel S. Steele

Watch author

Derived topics and classifications

psilocybin PTSD Emotional Processing Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-11 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?Journal of Pakistan Psychiatric Society · 2024-06-30 Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-21 Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).Professional Psychology Research and Practice · 2026-02-01 The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic ReviewJournal of Sociology Psychology & Religious Studies · 2023-11-06